Tag: Novo Nordisk A/S Series B

Business

To Pay for Weight Loss Drugs, Some Take Second Jobs, Ring Up Credit-Card Debts

September 1, 2023
Henry

Some people are paying more than $10,000 a year for Ozempic and Mounjaro.

Business

The Ozempic Craze Could Put These Companies on a Crash Diet

August 18, 2023
Henry

Anti-obesity medications could affect industries that benefit from America’s food problem.

Business

Drugs Like Ozempic Created a Gold Rush. These Drugmakers Want In.

July 16, 2023
Henry

Companies developing weight-loss drugs have raised or signed deals worth more than $1.4 billion since about…

Business

Eli Lilly to Acquire Obesity-Treatment Maker Versanis

July 14, 2023
Henry

Versanis shareholders could receive up to $1.925 billion in cash in the form of upfront payments…

Business

Europe Is Probing Whether Ozempic Use Raises Risk of Suicidal Thoughts

July 10, 2023
Henry

Ozempic is under review by European drug-safety regulators after reports of suicidal thoughts were linked to…

Business

The Drugs That Are Gaining On Ozempic

June 27, 2023
Henry

If they work safely, the treatments could help people lose enough weight that they could replace…

Business

Pill for Obesity Has Wall Street Salivating

June 26, 2023
Henry

Obesity treatment is currently limited to injections, but pills could expand the market and reduce costs.

Business

No More Shots: Pill Versions of Ozempic-Like Drugs Are Coming

June 25, 2023
Henry

The pills may appeal to people who want to lose weight but hate the needles that…

Business

Ozempic Maker Sues Spas and Clinics Selling Custom-Made Versions

June 20, 2023
Henry

Novo Nordisk accused the firms of false advertising, trademark infringement and unfair competition.

Business

FDA Warns About Safety of Custom-Made Ozempic

June 1, 2023
Henry

Some people have turned to pharmacies to make a solution containing the active ingredient, semaglutide.